Position Increase
Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. The Revenio Group's eye diagnostic solutions under the iCare brand include intraocular pressure measuring devices, fundus imaging devices and perimeters. The main tools for identifying, diagnosing and monitoring glaucoma during treatment are intraocular pressure measurement (tonometry), fundus imaging and visual field examination (perimetry).
Key figures
Year 2021e 2022e 2023e 2024e
growth% 27.3% 25.5% 23.8% 23.1%
EBIT-% 28.1% 31.4% 34.3% 35.0%
Dividend% 0.9% 1.2% 1.4% 2.0%
ROI-% 23% 30% 35% 37%
(prediction figures from inderes.fi, not mine)
Increased my position by 25%. Still fundamentally strong.
Key figures
Year 2021e 2022e 2023e 2024e
growth% 27.3% 25.5% 23.8% 23.1%
EBIT-% 28.1% 31.4% 34.3% 35.0%
Dividend% 0.9% 1.2% 1.4% 2.0%
ROI-% 23% 30% 35% 37%
(prediction figures from inderes.fi, not mine)
Increased my position by 25%. Still fundamentally strong.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.